L960-1029 Screening compound: 6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]methyl}-2,3-dihydropyridazin-3-one

L960-1029 Screening compound: 6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]methyl}-2,3-dihydropyridazin-3-one
L960-1029 Screening compound: 6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]methyl}-2,3-dihydropyridazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L960-1029
6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]methyl}-2,3-dihydropyridazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L960-1029

Molecular Formula

C18H16FN5O3 (C18 H16 FN5 O3)

Compound Name

6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-1,2,4-oxadiazol-3-yl]methyl}-2,3-dihydropyridazin-3-one

IUPAC name

6-(4-fluorophenyl)-2-{[5-(pyrrolidine-1-carbonyl)-124-oxadiazol-3-yl]methyl}-23-dihydropyridazin-3-one

SMILES

O=C(c1nc(CN(C(C=C2)=O)N=C2c(cc2)ccc2F)no1)N1CCCC1

InChI

InChI=1S/C18H16FN5O3/c19-13-5-3-12(4-6-13)14-7-8-16(25)24(21-14)11-15-20-17(27-22-15)18(26)23-9-1-2-10-23/h3-8H,1-2,9-11H2

InChI Key

HHAGOYKYITUGGW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27490164

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

369.36

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.848

Distribution Coefficient, logD

1.848

Water Solubility, LogSw

-2.24

Polar Surface Area

78.501

Acid Dissociation Constant (pKa)

27.95

Base Dissociation Constant (pKb)

0.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.80

L960-1029 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

C-Met Library (15277 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L960-1029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L960-1029?
Check Price and Availability of L960-1029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L960-1029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L960-1029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L960-1029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L960-1029 available by request